Goodwin
James Devendorf
- Deals
- 2
- Latest
- Apr 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Sarah Solomon 2 deals together
- Sarah Bock 2 deals together
- Dasol Lee 2 deals together
- Jennifer Fay 2 deals together
- Arman Oruc 2 deals together
- Danielle Fong 2 deals together
- Rachael Bushey 1 deal together
- Allison P. Nicklin 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Kelonia Therapeutics (target) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
Deals where James Devendorf is named on the firm's deal team, by the firm or the press.